Technical Analysis on Cardinal Health and Omnicare - Wholesale Drug
Companies Taking Good With the Bad
NEW YORK, NY -- (Marketwire) -- 11/08/12 -- Companies in the
wholesale drug industry, such as Cardinal Health Inc. and Omnicare
Inc., have been doing an admirable job of late. Sales for many
companies in the industry have contracted in recent quarterly
reports, as the impact of lower priced generics take their toll.
However, earnings have not followed the same trend in some cases, as
select companies have effectively cut costs and improved margins.
StBulls.com has initiated technical analysis on Cardinal Health Inc.
(NYSE: CAH) and Omnicare Inc. (NYSE: OCR) which serves the Drugs
Wholesale industry. These reports are free upon registration at
www.StBulls.com enthuses to bring the best from the internet under
one roof, providing you with a one click opportunity to view what the
market and financial researchers globally have to say about any
particular bellwether stocks in any given financial environment. To
be part of this community please sign up at
With the major shift from brand-to-generic drugs continuing,
companies that have a diversified portfolio of products could be
better equipped to deal with the continued patent expirations. A wide
range of product offerings are also a plus during times of economic
uncertainty, as companies do not have to rely on the success of only
a handful of products. Investors looking for technical analysis on
Omnicare Inc. are encouraged to use the link below
Also working in favor of the industry is the ageing baby-boomer
population. The U.S. is currently witnessing 10,000 baby boomers per
day crossing the 65-year-old mark, and this trend will continue for
more than fifteen years. With older people generally requiring more
medical attention, the industry could be well positioned for growth
moving forward. Read our technical analysis on Cardinal Health Inc.
by clicking on
About Street Bulls
STREET BULLS is committed to provide the investor
community with sharp and timely trading and investing advice. Our aim
is to help our readers achieve above-average returns from the markets
and create wealth for themselves. Our newsletters and trading advice
will provide investors with the information they need for success in
today's volatile markets.
To view our disclaimer, use this link
Press spacebar to pause and continue. Press esc to stop.